DEF 14A Filing

Company

Celldex Therapeutics, Inc.

Filed

April 12, 2004

Period of Report

May 13, 2004

Accession Number

0001145443-04-000574

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →